Molecular classification to refine surgical and radiotherapeutic decision-making in meningioma.

Saved in:
Bibliographic Details
Title: Molecular classification to refine surgical and radiotherapeutic decision-making in meningioma.
Authors: Wang JZ; MacFeeters Hamilton Neuro-Oncology Program, Princess Margaret Cancer Centre, University Health Network and University of Toronto, Toronto, Ontario, Canada.; Division of Neurosurgery, Department of Surgery, University of Toronto, Toronto, Ontario, Canada.; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada., Patil V; MacFeeters Hamilton Neuro-Oncology Program, Princess Margaret Cancer Centre, University Health Network and University of Toronto, Toronto, Ontario, Canada.; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada., Landry AP; MacFeeters Hamilton Neuro-Oncology Program, Princess Margaret Cancer Centre, University Health Network and University of Toronto, Toronto, Ontario, Canada.; Division of Neurosurgery, Department of Surgery, University of Toronto, Toronto, Ontario, Canada.; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada., Gui C; MacFeeters Hamilton Neuro-Oncology Program, Princess Margaret Cancer Centre, University Health Network and University of Toronto, Toronto, Ontario, Canada.; Division of Neurosurgery, Department of Surgery, University of Toronto, Toronto, Ontario, Canada.; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada., Ajisebutu A; MacFeeters Hamilton Neuro-Oncology Program, Princess Margaret Cancer Centre, University Health Network and University of Toronto, Toronto, Ontario, Canada.; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada., Liu J; MacFeeters Hamilton Neuro-Oncology Program, Princess Margaret Cancer Centre, University Health Network and University of Toronto, Toronto, Ontario, Canada.; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada., Saarela O; Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada., Pugh SL; NRG Oncology Statistics and Data Management Center, Philadelphia, PA, USA., Won M; NRG Oncology Statistics and Data Management Center, Philadelphia, PA, USA., Patel Z; Temerty School of Medicine, University of Toronto, Toronto, Ontario, Canada., Yakubov R; MacFeeters Hamilton Neuro-Oncology Program, Princess Margaret Cancer Centre, University Health Network and University of Toronto, Toronto, Ontario, Canada.; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada., Kaloti R; MacFeeters Hamilton Neuro-Oncology Program, Princess Margaret Cancer Centre, University Health Network and University of Toronto, Toronto, Ontario, Canada.; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada., Wilson C; Neurosurgery Specialists of Tulsa, Tulsa, OK, USA., Cohen-Gadol A; Department of Neurological Surgery, Keck School of Medicine of the University of Southern California, Los Angeles, CA, USA., Zaazoue MA; Department of Neurological Surgery, Indiana University School of Medicine, Indianapolis, IN, USA.; Department of Orthopedic Surgery, Washington University School of Medicine in St. Louis, St. Louis, MO, USA., Tabatabai G; German Cancer Consortium (DKTK), DKFZ Partner Site Tübingen, Tübingen, Germany.; Cluster of Excellence (EXC 2180) 'Image Guided and Functionally Instructed Tumor Therapies', Eberhard Karls University Tübingen, Tübingen, Germany.; Department of Neurology and Interdisciplinary Neuro-Oncology, Center for Neuro-Oncology, Comprehensive Cancer Center, Hertie Institute for Clinical Brain Research, Eberhard Karls University Tübingen, Tübingen, Germany., Tatagiba M; Department of Neurosurgery, Center for Neuro-Oncology, Comprehensive Cancer Center, Eberhard Karls University Tübingen, Tübingen, Germany., Behling F; Department of Neurosurgery, Center for Neuro-Oncology, Comprehensive Cancer Center, Eberhard Karls University Tübingen, Tübingen, Germany., Almiron Bonnin DA; Department of Pathology, University of San Francisco, San Francisco, CA, USA., Holland EC; Human Biology Division, Fred Hutchinson Cancer Center, Seattle, WA, USA., Kruser TJ; Department of Human Oncology, University of Wisconsin Hospitals and Clinics, Madison, WI, USA., Barnholtz-Sloan JS; Central Brain Tumor Registry of the United States, Hinsdale, IL, USA.; Trans Divisional Research Program (TDRP), Division of Cancer Epidemiology and Genetics (DCEG), National Cancer Institute, Bethesda, MD, USA.; Center for Biomedical Informatics & Information Technology (CBIIT), National Cancer Institute, Bethesda, MD, USA., Sloan AE; Piedmont Brain Tumor Center, Piedmonth Healthcare System, Atlanta, GA, USA., Horbinski C; Department of Pathology, Northwestern University, Evanston, IL, USA.; Lou & Jean Malnati Brain Tumor Institute at the Lurie Comprehensive Cancer Center, Northwestern University, Evanston, IL, USA., Chotai S; Department of Neurosurgery, Vanderbilt University Medical Center, Nashville, TN, USA., Chambless LB; Department of Neurosurgery, Vanderbilt University Medical Center, Nashville, TN, USA., Gao A; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada., Rebchuk AD; Division of Neurosurgery, University of British Columbia, Vancouver, British Columbia, Canada., Makarenko S; Division of Neurosurgery, University of British Columbia, Vancouver, British Columbia, Canada., Yip S; Department of Pathology & Laboratory Medicine, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada., Sahm F; Department of Neuropathology, Institute of Pathology, Ruprecht-Karls-University Heidelberg, Heidelberg, Germany.; Clinical Cooperation Unit Neuropathology, German Cancer Research Center (DKFZ), Heidelberg, Germany., Maas SLN; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.; Department of Pathology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands., Tsang DS; Radiation Medicine Program, Princess Margaret Cancer Centre, Toronto, Ontario, Canada., Rogers CL; Radiation Oncology, Utah Cancer Specialists, Salt Lake City, UT, USA., Aldape K; Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA., Nassiri F; MacFeeters Hamilton Neuro-Oncology Program, Princess Margaret Cancer Centre, University Health Network and University of Toronto, Toronto, Ontario, Canada. farshad.nassiri@uhn.ca.; Division of Neurosurgery, Department of Surgery, University of Toronto, Toronto, Ontario, Canada. farshad.nassiri@uhn.ca.; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada. farshad.nassiri@uhn.ca., Zadeh G; MacFeeters Hamilton Neuro-Oncology Program, Princess Margaret Cancer Centre, University Health Network and University of Toronto, Toronto, Ontario, Canada. gelareh.zadeh@uhn.ca.; Division of Neurosurgery, Department of Surgery, University of Toronto, Toronto, Ontario, Canada. gelareh.zadeh@uhn.ca.; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada. gelareh.zadeh@uhn.ca.; Arthur and Sonia Labatt Brain Tumour Research Centre, The Hospital for Sick Children, Toronto, Ontario, Canada. gelareh.zadeh@uhn.ca.
Corporate Authors: International Consortium on Meningiomas (ICOM)
Source: Nature medicine [Nat Med] 2024 Nov; Vol. 30 (11), pp. 3173-3183. Date of Electronic Publication: 2024 Aug 21.
Publication Type: Journal Article
Journal Info: Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1546-170X
DOI:10.1038/s41591-024-03167-4